| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | SUVALENT THERAPEUTICS INC. | 1290 RANCHO CONEJO BLVD, STE 101F | THOUSAND OAKS | CA | 91320-1408 | VENTURA | USA | R43CA217349 | Development of an oral drug targeting SUMOylation | 000 | 1 | NIH | 12/9/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43CA239820 | Orally available allosteric inhibitor of protein sumoylation | 000 | 1 | NIH | 7/1/2020 | $0 |
| | 2020 | 2018 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43CA217349 | Development of an oral drug targeting SUMOylation | 000 | 1 | NIH | 11/7/2019 | $0 |
| | 2020 | 2018 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43CA217349 | Development of an oral drug targeting SUMOylation | 001 | 1 | NIH | 7/6/2020 | $0 |
| | 2020 | 2016 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 3 | NIH | 2/19/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $300,000 ) |
| | 2019 | 2019 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43CA239820 | Orally available allosteric inhibitor of protein sumoylation | 000 | 1 | NIH | 7/18/2019 | $300,000 |
|
| Issue Date FY: 2018 ( Subtotal = $232,759 ) |
| | 2018 | 2018 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R43CA217349 | Development of an oral drug targeting SUMOylation | 000 | 1 | NIH | 9/18/2018 | $232,759 |
| | 2018 | 2016 | SUMO BIOSCIENCES INC. | 2265 E FOOTHILL BLVD | PASADENA | CA | 91107-3658 | LOS ANGELES | USA | R44CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 3 | NIH | 9/3/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,208,769 ) |
| | 2016 | 2016 | SUMO BIOSCIENCES LLC | 94 ONTARE RD | ARCADIA | CA | 91006-1839 | LOS ANGELES | USA | R44CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 3 | NIH | 7/18/2016 | $1,208,769 |
|
| Issue Date FY: 2015 ( Subtotal = $788,879 ) |
| | 2015 | 2015 | SUMO BIOSCIENCES LLC | 94 ONTARE RD | ARCADIA | CA | 91006-1839 | LOS ANGELES | USA | R44CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 2 | NIH | 8/4/2015 | $1 |
| | 2015 | 2015 | SUMO BIOSCIENCES LLC | 94 ONTARE RD | ARCADIA | CA | 91006-1839 | LOS ANGELES | USA | R44CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 2 | NIH | 8/4/2015 | $788,878 |
|
| Issue Date FY: 2014 ( Subtotal = $224,999 ) |
| | 2014 | 2014 | SUMO BIOSCIENCES LLC | 94 ONTARE RD | ARCADIA | CA | 91006-1839 | LOS ANGELES | USA | R43CA189499 | Design of a Covalent Inhibitor for c-Myc-Dependent Cancers | 000 | 1 | NIH | 7/8/2014 | $224,999 |
|
|
